Oramed Pharmaceuticals Number of Employees 2011-2024 | ORMP
Oramed Pharmaceuticals number of employees from 2011 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Oramed Pharmaceuticals Annual Employee Count | |
|---|---|
| 2023 | 15 |
| 2022 | 17 |
| 2021 | |
| 2021 | 13 |
| 2020 | 12 |
| 2019 | 13 |
| 2018 | 13 |
| 2017 | 14 |
| 2016 | 12 |
| 2015 | |
| 2014 | |
| 2013 | |
| 2012 | |
| 2012 | |
| 2011 | |
| 2011 | |
| 2010 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.091B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.514B | 24.03 |
| Stryker (SYK) | United States | $129.352B | 30.98 |
| Boston Scientific (BSX) | United States | $113.715B | 36.22 |
| Medtronic (MDT) | Ireland | $103.107B | 15.43 |
| EssilorLuxottica (ESLOY) | France | $101.762B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.392B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.132B | 28.57 |
| ResMed (RMD) | United States | $27.007B | 25.36 |
| Terumo (TRUMY) | Japan | $24.269B | 34.27 |
| Koninklijke Philips (PHG) | Netherlands | $23.059B | 18.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.264B | 14.22 |
| Baxter (BAX) | United States | $17.305B | 12.30 |
| Insulet (PODD) | United States | $14.411B | 63.90 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.994B | 26.14 |
| BellRing Brands (BRBR) | United States | $7.556B | 35.54 |
| Lantheus Holdings (LNTH) | United States | $5.677B | 14.15 |
| GN Store Nord (GNNDY) | Denmark | $4.364B | 24.51 |
| Haemonetics (HAE) | United States | $4.251B | 20.96 |
| Perrigo (PRGO) | Ireland | $3.490B | 10.58 |
| Neogen (NEOG) | United States | $3.487B | 33.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.449B | 16.41 |
| TG Therapeutics (TGTX) | United States | $2.966B | 83.43 |
| ICU Medical (ICUI) | United States | $2.799B | 24.70 |
| Envista Holdings (NVST) | United States | $2.750B | 11.35 |
| Green Thumb Industries (GTBIF) | United States | $2.568B | 50.27 |
| Agios Pharmaceuticals (AGIO) | United States | $2.537B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.203B | 12.23 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 53.87 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.731B | 0.00 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| InMode (INMD) | Israel | $1.512B | 8.04 |
| AdaptHealth (AHCO) | United States | $1.289B | 9.58 |
| Verano Holdings (VRNOF) | United States | $1.266B | 0.00 |
| Owens & Minor (OMI) | United States | $1.179B | 10.27 |
| AtriCure (ATRC) | United States | $1.013B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.006B | 32.00 |
| BioLife Solutions (BLFS) | United States | $0.984B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.710B | 15.12 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| Evolus (EOLS) | United States | $0.654B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.590B | 13.88 |
| Valneva SE (VALN) | France | $0.520B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.21 |
| Canopy Growth (CGC) | Canada | $0.494B | 0.00 |
| Quanterix (QTRX) | United States | $0.485B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 10.33 |
| Jin Medical (ZJYL) | China | $0.432B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.417B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Zynex (ZYXI) | United States | $0.274B | 37.52 |
| MacroGenics (MGNX) | United States | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.245B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.90 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 67.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.116B | 0.00 |
| Brainsway (BWAY) | Israel | $0.104B | 0.00 |
| InterCure (INCR) | Israel | $0.099B | 16.77 |
| Fonar (FONR) | United States | $0.099B | 10.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Bright Green (BGXX) | United States | $0.061B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |